Back

Lilly's Taltz and Zepbound combination shows durable efficacy at one year

Verifying
  • Lilly reported new Phase 3b data on Taltz and Zepbound used together.
  • Efficacy improved and remained durable at one year.
  • The data involved adults with psoriatic disease and obesity.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.